Bristol Myers Squibb news
The latest Bristol Myers Squibb news, : Anthropic partners with pharma firms to cut document review by 89%.
The available coverage does not provide a definition of Bristol Myers Squibb. Recent stories focus on Anthropic’s AI model Claude discovering a CRISPR‑like enzyme system, Anthropic opening a wet‑biology lab for AI‑directed experiments, and Owkin’s CEO Thomas Clozel discussing AI‑driven cancer research.
4 stories mentioning Bristol Myers Squibb since 23 September 2026, newest first, each with its sources and discussion. Follow to see new ones on your front page.
-
Anthropic partners with pharma firms to cut document review by 89%
Anthropic is expanding its Claude AI model into pharmaceutical research, collaborating with biotech firms to accelerate drug development. The company detailed these efforts in a new blog post, highlighting projects…
1 sourcetech.yahoo.com -
Google announces Gemini 4 Carbon, its latest frontier AI model for cybersecurity
Google announced Gemini 4 Carbon on October 28, 2026, as its newest frontier AI model, succeeding Gemini 4 Argon released two weeks prior. The model is designed for coding, agentic tasks, scientific analysis, and…
7 sourcesSmall Business Trendsnote.comengadget.comUnite.AI +2 more -
Anthropic details drug development work with six partners and acquires Mithril
Anthropic disclosed deep research partnerships with six life-sciences organizations — BigHat Biosciences, Bristol Myers Squibb, Divergence Labs, Enveda, Generate Biomedicines, and The Column Group — and said it…
3 sources primary source HN 39finance.yahoo.comanthropic.comUnite.AI -
Anthropic’s AI Claude discovers CRISPR-like enzyme system ART
Anthropic announced that its AI model Claude autonomously discovered a new enzyme system called array-associated reverse transcriptases (ART) in a DNA sequence database, noting structural similarities to CRISPR. The…
26 sources HN 7MIT Technology Review AIcnet.comnote.comthedailystar.net +18 more
Questions about Bristol Myers Squibb
What is the latest Bristol Myers Squibb news?
As of 1 November 2026: Anthropic partners with pharma firms to cut document review by 89%. Anthropic is expanding its Claude AI model into pharmaceutical research, collaborating with biotech firms to accelerate drug development.
What is Bristol Myers Squibb?
The available coverage does not provide a definition of Bristol Myers Squibb. Recent stories focus on Anthropic’s AI model Claude discovering a CRISPR‑like enzyme system, Anthropic opening a wet‑biology lab for AI‑directed experiments, and Owkin’s CEO Thomas Clozel discussing AI‑driven cancer research.